Vismodegib in Treating Patients With Advanced Chondrosarcomas
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well vismodegib works in treating patients with
chondrosarcomas that have spread to other places in the body and usually cannot be cured or
controlled with treatment. Drugs used in chemotherapy, such as vismodegib, work in different
ways to stop the growth of tumor cells, either by killing the cells, by stopping them from
dividing, or by stopping them from spreading.